Profile photo Tom Snijders

Tom Snijders

Associate Professor - medical

Strategic program(s):

Biography

T.J. (Tom) Snijders, PhD, completed his medical studies and his Neurology residency in the UMC Utrecht. During his training, he obtained a PhD-degree in the field of chronic pain medicine. He sub-specialized in Neuro-oncology during his residency.

Since 2011, he works as a neurologist and assistant professor in the UMC Utrecht. His practice encompasses all aspects of neuro-oncological patient care. His scientific work focuses on primary brain tumors, specifically gliomas. He is the co-coordinator, with prof. Elly Hol, of the Disease Area Neuro-oncology of the UMC Utrecht Brain Center.  He is co-supervisor of 5 completed or ongoing PhD-trajectories. He is also involved in providing and evaluating experimental treatments (international clinical trials) in the UMC Utrecht.

Research interests:

  • Validation and innovation of imaging techniques for brain tumors, including MRI-scans and PET-scans
  • Pseudoprogression in glioma and other brain tumors
  • Cognitive symptoms in glioma patients
  • Epilepsy due to brain tumors
  • Liquid biopsy in primary brain tumors
  • Focused Ultrasound and blood-brain-barrier disruption for brain tumor treatment
  • The multidisciplinary Team Neuro-Oncology of the UMC Utrecht aims to provide patients with the most recent innovative (experimental) treatments for brain tumors as part of clinical studies.

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

Postoperative ischemia and neurological deficits after glioma resection Arthur T.J. van der Boog, Eva E. van Grinsven, Matea Rados, Tom J. Snijders, Joost J.C. Verhoeff, Pierre A. Robe
Neuro-Oncology Practice, 2026, vol. 13, p.452-464
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG) A M de Jong, A T J van der Boog, C C B Post, F Cialdella, D B P Eekers, J Hendrikse, M C A Kramer, F J Lagerwaard, M van der Meulen, M E P Philippens, P A Robe, T Rozema, F Y F L de Vos, J Vos-Westerman, H L van der Weide, G Wester, J Zindler, T J Snijders, J J C Verhoeff
PLoS ONE, 2026, vol. 21
Efficacy of Intra-arterial [177Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma A. El Ghalbouni, T. J. Snijders, A. Amerein, N. Tolboom, M. Patt, C. J. Maurer, I. C. van der Schaaf, C. Lapa, A. J.A.T. Braat
Journal of Neuro-Oncology, 2026, vol. 176, p.1-9
Simultaneous Gadolinium-free MR Angiography, Venography and Relaxometry using a fast 3D MR-STAT protocol Bas Schilder, Stefano Mandija, Hanna Liu, Edwin Versteeg, Miha Fuderer, Oscar van der Heide, Mark Haacke, Thierry Meerbothe, Tom Snijders, P Robe, Nico van den Berg, Alessandro Sbrizzi
2025, p.1210
More accurate synthetic MRI to shorten clinical protocols F Xu, Edwin Versteeg, Oscar van der Heide, Kyung Min Nam, Stefano Mandija, Bas Schilder, P Robe, Tom Snijders, Nico van den Berg, Alessandro Sbrizzi
2025, p.5214
New biomarkers for the diagnosis of primary central nervous system lymphoma in CSF Josephus L M van Rooij, Peter H Wessels, Eveline M Delemarre, Bob Meek, Henk J T Ruven, Tatjana Seute, Monique C Minnema, Stefan Nierkens, Tom J Snijders
Neuro-oncology advances, 2025, vol. 7

External positions

editorial board member - editorial work & peer review - Neuro Oncology Practice

reviewer board member - peer review - MDPI Cancers (Basel)

member (ongoing), steering committee member (2021-2024), imaging committee member (2018-2024), - organization and planning of scientific research - EORTC Brain Tumor group

Committee Member - richtlijn opstellen/onderhouden - Task Force on Bing Neel Syndrome

Guideline committee ‘Intracranial meningioma', member (2012-2015), chairperson (since 2023) - writing a guideline, leading the team - Kennisinstituut/NVN

Chairperson/chief (until 2023), member (since 2023) - writing and editing medical information on website; answering questions from kanker.nl - Editorial board (‘redactieraad’) of Hersentumor.nl